Simson Pharma Limited, a active public limited company, was established on 19 April 2018 in Mumbai, Maharashtra, India. Engaging in online healthcare product retail within the manufacturing sector, it holds CIN: U24230MH2018PLC308280. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹15.00 Cr and a paid-up capital of ₹10.00 Cr.
Employing 218 professional, Its leadership includes Bhavika Penchala (Director), Satyanarayana Rao Penchala (Managing Director), Manga Rani Penchala (Director). Past directors included Satyanarayana Rao Penchala, Pratik Kumar Agarwal. It holds ₹1.25 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Gala No-B/307, 3Rd Floor, New Sarita Bldg. Prabhat Indl Complex, Dahisar East, Mumbai, Maharashtra, 400068.
U24230MH2018PLC308280
308280
19 April 2018
₹15.00 Cr
₹10.00 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Simson Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bhavika Penchala | Director | 19 Apr 2018 | Current |
| Satyanarayana Rao Penchala | Managing Director | 19 Apr 2018 | Current |
| Manga Rani Penchala | Director | 19 Apr 2018 | Current |
| Sonit Sai Penchala | Additional Director | 14 Aug 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Aug 2018 | Past |
| Pramod Abcsdd | Cfo | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Simson Pharma Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 28.21% increase. The company also saw a substantial improvement in profitability, with a 27.3% increase in profit. The company's net worth Soared by an impressive increase of 46.93%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Simson Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹12,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Oct 2023 | Idbi Bank Limited | ₹1.25 Cr | Open |
Explore comprehensive loan charge details -
Simson Pharma has a workforce of 218 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Simson Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Simson Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Pratik Kumar Agarwal was appointed as a Cfo was appointed as a Cfo on 10 Sep 2025 & has been associated with this company since 2 months 22 days . was recorded as a recent event.
Progress on Sonit Sai Penchala was appointed as a Additional Director was appointed as a Additional Director on 14 Aug 2025 & has been associated with this company since 3 months 18 days . was documented.
Simson Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Simson Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
The activity A charge with Idbi Bank Limited amounted to Rs. 1.25 Cr with Charge ID 100845060 was registered on 13 Oct 2023. was completed.
Progress on Bhavika Penchala was appointed as a Director was appointed as a Director on 19 Apr 2018 & has been associated with this company since 7 years 7 months . was documented.
The CIN of Simson Pharma Limited is U24230MH2018PLC308280.
Simson Pharma Limited is headquartered at Gala No-B/307, 3Rd Floor, New Sarita Bldg. Prabhat Indl Complex, Dahisar East, Mumbai, Maharashtra, 400068.
Simson Pharma Limited was incorporated on 19 April 2018.
The current directors of Simson Pharma Limited are
The primary industry of Simson Pharma Limited is Manufacturing.
Simson Pharma Limited is unlisted.
The authorized capital of Simson Pharma Limited is ₹15.00 Cr, and the paid-up capital is ₹10.00 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX